%20(2).png)
Webinars
EGFR/HER2 Yale Cancer Vaccine
Dec 2025
Mark Mamula PhD, Yale University
CCA Funded Research: How a new cancer immunotherapy may help dogs with osteosarcoma, hemangiosarcoma and urothelial carcinoma
Liquid Biopsy for Canine Cancer Monitoring
Dec 2025
Maciej Parys PhD, CanCan Diagnostics
A new liquid biopsy test available today for canine cancer monitoring
Watch here.
What causes hemangiosarcoma? - Environmental Exposures and Canine Cancer Risk
Oct 2025
Catherine Wise PhD, Duke University
​CCA Funded Research: Emerging evidence linking chemical exposure to increased cancer risk in dogs
Watch here.
Remarkable 12 month survival-rate with Elias Immunotherapy
Aug 2025
Jeffrey Bryan DVM, PhD
How Elias Immunotherapy helps activate the dog's own immune system and can cure dogs with very aggressive cancer
Could This Combination Immunotherapy Help Dogs Beat Osteosarcoma (and other aggressive cancers)?
July 2025
Brian Flesner PhD
A new combination immunotherapy sponsored by Ardent Animal Health
Finding better, less toxic cancer treatments for dogs with a new genomic test?
July 2025
Guannan Wang PhD, VetOmics
Introduction of CGP and explanation of when it could help find treatments that are most suited to their dog's cancer
Watch here.
These Three Dogs With Metastatic Cancer Made Amazing Recovery
April 2025
Story of three pups with metastatic cancer that made a recovery thanks to the EGFR/HER2 vaccine
Canine Cancer Causes and Prevention
Mar 2025
Explores the latest science on canine cancer, including environmental toxins, breed risks, gut health, and prevention strategies.
Watch here.
Surprising Cancer Discoveries You Need to Know
Feb 2025
Explores surprising findings in canine cancer research and treatments that could change how we approach cancer in dogs and even humans
EGFR/HER2 Yale Canine Cancer Vaccine Update
Oct 2024
Mark Mamula PhD, Yale University
CCA Funded Research: Update on the canine cancer immunotherapy clinical trial "Tina's Trial"
Watch here.
EGFR/HER2 Yale Canine Cancer Vaccine Clinical Trial
April 2024
Mark Mamula PhD, Yale University
CCA Funded Research: Review of Prof. Mamula's canine cancer immunotherapy study and some early findings from "Tina's Trial
The promise of immunotherapy and 2024 directions
What makes cancer immunotherapy promising and what its limits are
Feb 2024
Watch here.
Gut Microbiome Can Impact Canine Cancer Treatment Response
Oct 2024
Recent findings about how human patients who were not responding to immunotherapy became responders with the help of alteration to the gut microbiome.
Watch here.